Cargando…
Accelerating Pneumococcal Conjugate Vaccine introductions in Indonesia: key learnings from 2017 to 2022
Despite high pneumococcal disease and economic burden in Indonesia and interest to introduce pneumococcal conjugate vaccine (PCV), there were challenges in establishing a comprehensive strategy to accelerate and enable the introduction in country in the early 2010s. Starting in 2017, Clinton Health...
Autores principales: | Athiyaman, Anithasree, Herliana, Putri, Anartati, Atiek, Widyastuti, Niken, Yosephine, Prima, Tandy, Gertrudis, Karolina, Sherli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10683141/ https://www.ncbi.nlm.nih.gov/pubmed/38017524 http://dx.doi.org/10.1186/s40249-023-01161-5 |
Ejemplares similares
-
Cost-Effectiveness and Budget Impact Analyses of Pneumococcal Vaccination in Indonesia
por: Suwantika, Auliya A., et al.
Publicado: (2021) -
Progress Toward Measles and Rubella Elimination — Indonesia, 2013–2022
por: Chacko, Stephen, et al.
Publicado: (2023) -
Post Marketing Surveillance Study of 2(nd) Dose Quadrivalent Human Papilloma Virus Vaccine in Elementary School Children in Jakarta, Indonesia: Safety Result and Implementation of School-Based HPV Immunization Program
por: Satari, Hindra Irawan, et al.
Publicado: (2019) -
Determinants of immunisation coverage of children aged 12–59 months in Indonesia: a cross-sectional study
por: Herliana, Putri, et al.
Publicado: (2017) -
Impact of Switch Options on the Economics of Pneumococcal Conjugate Vaccine (PCV) Introduction in Indonesia
por: Suwantika, Auliya A., et al.
Publicado: (2020)